The global decrease in cancer mortality: trends and disparities
D Hashim, P Boffetta, C La Vecchia, M Rota, P Bertuccio, M Malvezzi, E Negri, D Hashim, P Boffetta, C La Vecchia, M Rota, P Bertuccio, M Malvezzi, E Negri
Abstract
Background: A decrease in cancer mortality has been reported in the United States, Europe, and other high-income regions during the last two decades. Whether similar trends apply to low-to-middle income countries-and globally-is unclear.
Design: The aim of this descriptive study is to compare cancer mortality in all countries with high- or intermediate-quality data on death certificates according to the World Health Organization (WHO) mortality database for the years 2000 through 2010. We included 60 countries in the analysis and calculated age-adjusted mortality rates for all cancer combined and for the commonest cancers worldwide: lung, stomach, breast, colorectal, uterine, and prostate.
Results: A decrease in overall cancer mortality rate of ∼1% per year was observed in higher and lower income regions and in both sexes. In 2010, 696 000 cancer deaths were avoided on a global scale compared with 2000 rates (426 000 in men, 271 000 in women). However, the mortality of liver cancer in both sexes and lung cancer in females increased in many countries'.
Conclusions: The individual risk of dying from cancer decreased in all countries with reliable data. This decrease was chiefly due to favorable trends in the commonest specific cancers. Liver cancer in both sexes and lung cancer in women, which show increasing mortality rates, constitute a priority for prevention and further research.
Keywords: cancer; data collection/standards; global health; mortality; registries/standards; vital statistics.
© The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Source: PubMed
Prochains essais cliniques
-
National Center for Complementary and Integrative...RecrutementLa douleur | Volontaires en bonne santé | Physiologie normaleÉtats-Unis
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); GlaxoSmithKline; Genentech, Inc.; Brain Science...RecrutementMéningiome intracrânien | Méningiome récurrent | Mutation du gène NF2États-Unis
-
National Institute of Allergy and Infectious Diseases...RecrutementVMC | VPH | VEB | HSV | VZVÉtats-Unis
-
National Institute on Drug Abuse (NIDA)RecrutementDépendance à la nicotine | Abus de drogueÉtats-Unis
-
National Institute of Allergy and Infectious Diseases...RecrutementGrippe | ZikaÉtats-Unis
-
National Institutes of Health Clinical Center (CC)RecrutementHypertension pulmonaire | Maladie pulmonaireÉtats-Unis
-
National Human Genome Research Institute (NHGRI)Recrutement
-
National Institutes of Health Clinical Center (CC)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... et autres collaborateursRecrutementHypertension artérielle pulmonaireÉtats-Unis
-
National Human Genome Research Institute (NHGRI)RecrutementAnomalie congénitale | Troubles rares | Des handicaps intellectuelsÉtats-Unis
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecrutementB Leucémie aiguë lymphoblastiqueÉtats-Unis, Canada
-
National Cancer Institute (NCI)RecrutementCarcinome pulmonaire non à petites cellules avancé | Carcinome pulmonaire non à petites cellules récurrent | Cancer du poumon non à petites cellules de stade IIIB AJCC v7 | Cancer du poumon non à petites cellules de stade IV AJCC v7États-Unis
-
National Institute of Arthritis and Musculoskeletal...RecrutementVolontaires en bonne santé | Carcinome, cellule de Merkel | Volontaires normaux | Conditions dermatologiquesÉtats-Unis